1)平原佐斗司,他:非がん疾患の在宅ホスピス・緩和ケアに関する多施設共同研究.2006年度在宅医療助成勇美記念財団研究
2)日本呼吸器学会COPDガイドライン第5版作成委員会(編):COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン,第5版,メディカルレビュー社,2018
3)日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会(編):特発性間質性肺炎 診断と治療の手引き,改訂第3版,南江堂,2016
4)Connors AF, et al:A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments(SUPPORT). The SUPPORT Principal Investigators. JAMA 274:1591-1598, 1995
5)Celli BR, et al:The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005-1012, 2004
6)Vermylen JH, et al:Palliative care in COPD;An unmet area for quality improvement. Int J Chron Obstruct Pulmon Dis 10:1543-1551, 2015
7)Ley B, et al:A multidimensional index and staging system for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 184:459-466, 2011
8)Kondoh Y, et al:Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir Rev 26:170050, 2017
9)桂 秀樹:慢性閉塞性肺疾患の終末期医療と緩和ケアの意義.日本臨床61:2212-2219, 2003
10)Higginson IJ, et al:An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness;A randomised controlled trial. Lancet Respir Med 2:979-987, 2014
11)Campbell ML, et al:A Respiratory Distress Observation Scale for patients unable to self-report dyspnea. J Palliat Med 13:285-290, 2010
12)Rocker G, et al:Palliation of dyspnea in advanced COPD;Revisiting a role for opioids. Thorax 64:910-915, 2009
13)Lanken PN, et al:An official American Thoracic Society clinical policy statement;Palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 177:912-927, 2008
14)有田健一,他:過去20年間における肺線維症・間質性肺炎終末期の緩和医療に関する検討.日本胸部臨床69:353-361, 2010